Sign In
Buy SNY
$43.98
-0.680 (-1.52%)
At Close: Jul 20, 2026
PARIS, March 31, 2021 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Sarclisa® (isatuximab-irfc) in combination with carfilzomib and dexamethasone (Kd), for the treatment
Daiichi Axes Sanofi Vaccine Pact After Pertussis Jab Manufacturing Faces Snag
01:46pm, Wednesday, 31'st Mar 2021
Though Daiichi Sankyo (OTCMKTS: DSNKY) and Sanofi SA (NASDAQ: SNY) came forward to help produce other pharmas' COVID-19 shots, the companies are calling it quits on their own, separate vaccine al
Canadian Government, Sanofi To Build C$925M Flu Vaccine Facility In Toronto
11:57am, Wednesday, 31'st Mar 2021
Sanofi SA (NASDAQ: SNY) is dropping a major investment into its supply chain by shelling C$925 million to build a new manufacturing facility in Toronto. The new facility will be operational by 202
